Genital candidiasis: topical management with clotrimazole.
Clotrimazole was administered in the form of 100 mg tablets to patients with vaginal candidiasis, and in the form of a 1% solution to patients with cutaneous candidiasis of the genital and perigenital areas. The clinical and mycological response observed and the excellent tolerance and lack of side effects indicate that clotrimazole may be proposed as a treatment for candidiasis.
D000284:Administration, Oral; D000287:Administration, Topical; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003022:Clotrimazole / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*
D007093:Imidazoles; D003022:Clotrimazole